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Solid organ transplant (SOT) recipients are especially at risk of developing infections by multidrug 
resistant bacteria (MDR). In this study, the biofilm-forming capability of 209 MDR strains (Escherichia 
coli n = 106, Klebsiella pneumoniae n = 78, and Enterobacter spp. n = 25) isolated from rectal swabs in 
the first 48 hours before or after kidney (93 patients), liver (60 patients) or kidney/pancreas transplants 
(5 patients) were evaluated by using a microplate assay. Thirty-nine strains were isolated before 
transplant and 170 strains were isolated post-transplant. Overall, 16% of E. coli strains, 73% of K. 
pneumoniae strains and 4% Enterobacter strains showed moderate or strong biofilm production. Nine 
strains isolated from infection sites after transplantation were responsible of infections in the first 
month. Of these, 4 K. pneumoniae, 1 E. coli and 1 Enterobacter spp. strains isolated pre-transplant or 
post-transplant as colonizers caused infections in the post-transplant period. Our results suggest that  
in vitro biofilm formation could be an important factor for adhesion to intestine and colonization in MDR 
K. pneumoniae strains in SOT recipients, but this factor appears to be less important for MDR E. coli and 
Enterobacter spp.
Solid organ transplant (SOT) recipients have an increased risk of developing bacterial infections because they 
receive long immunosuppressive therapy to avoid rejection. Furthermore, SOT recipients are especially at risk of 
developing infections by bacteria with intrinsic or acquired antimicrobial resistance as they are frequently exposed 
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to antibiotics in healthcare settings1–3. Currently, the increasing prevalence of multi-drug resistant (MDR) 
Gram-negative pathogens, such as extended-spectrum β-lactamase-producing (ESBLs) Enterobacteriaceae 
strains, strains with overproduction of intrinsic chromosomal AmpC β-lactamases4,5, and carbapenem-resistant 
K. pneumoniae and E. coli strains, are of particular concern in SOT recipients.
Important risk factors for nosocomial infections in SOT recipients are, among others, the use of catheters, 
hospitalization in intensive care units, and pre-transplant faecal carriage of multidrug-resistant isolates6,7.
The Enterobacteriaceae family is a heterogeneous group of Gram-negative bacteria, whose natural habitat is 
the intestinal tract of humans and animals. Among the hospital-acquired infections due to Enterobacteriaceae, 
urinary tract infections (UTIs) are the most common and lower respiratory tract and bloodstream infections are 
the most lethal8–10. Virulence factors in Enterobacteriaceae include different adhesins, hemolysin production, 
serum resistance, and biofilm formation. These factors, especially the ability to form biofilms in the human intes-
tine may contribute to gut colonization and have a great impact on the function of the intestinal microbiome and 
its interactions with the host11–19.
A biofilm is often defined as a structured community of microorganisms enclosed in a self-produced matrix 
and adherent to an inert or living surface. Growth in biofilms enhances the survival of bacterial populations in 
hospital settings and inside patients, increasing the probability of causing nosocomial infections20–22. Also, several 
investigations have revealed that horizontal gene transfer is connected with biofilm formation23,24.
Previous studies showed a relationship between the presence of antimicrobial resistance genes and biofilm 
formation in E. coli and Klebsiella strains isolated from patients with different infections14,25,26, however, the cor-
relation between antibiotic resistance and biofilm formation for most pathogens (i.e. Enterobacter spp.) remains 
unclear. The goal of present study, which is part of a wider research project (The ENTHERE study), was to analyse 
the capacity to form biofilm of 209 Enterobacteriaceae strains isolated from pre- or post-transplant patients. This 
investigation could contribute to a better understanding the relationship between adherence capability, antimi-
crobial resistance, and pathogenicity of MDR bacteria in SOT recipients.
Results
Antibiotic resistance genes. The most common genes found in the strains isolated in this study were 
extended-spectrum β-lactamases, followed by carbapenemases, being blaCTXM and blaSHV most prevalent in 
E. coli, blaCTXM and blaOXA-48 in K. pneumoniae and blaCTXM and AmpC hyperproduction in Enterobacter spp. 
Distribution of antibiotic resistance genes in Enterobacteriaceae strains isolated from transplant patients is shown 
in Table 1.
Hemagglutination in E. coli strains. Hemagglutination (HA) was observed in 23 strains (21.7%). HA was 
mannose sensitive (MS) in 9 strains (8.5%) and mannose resistant (MR) in 14 strains (13.2%) (Supplementary 
Table 1). We observed an inverse relationship between hemagglutinating strains and biofilm formation, because 
the isolates that show either sensitivity or resistance to the hemagglutination in presence of mannose are non- or 
weak biofilm former strains.
Biofilm formation by Enterobacteriaceae strains. The ability of Enterobacteriaceae strains to form 
biofilms was quantified by crystal violet (CV) staining after 48 h at 37 °C. Bacterial growth was, in general, not 
strongly influenced by the culture conditions, as estimated by the colony forming units (CFU) of planktonic cells 
in 4 strains of each species, with numbers in the range from 1.95 × 108 to 6.45 × 108 CFUs/well. All the biofilms 
were found at the liquid-air interface. Overall, 16% of E. coli strains and 73% of K. pneumoniae strains showed 
moderate or strong biofilm production while only one Enterobacter strain showed moderate biofilm production 
(Fig. 1).
Seventy-two percent of 67 K. pneumoniae isolates shown moderate or strong biofilm formation (23 from renal 
transplants and 25 from hepatic transplants) whereas only 16 post-transplant E. coli isolates (19.5%) were biofilm 
forming strains, mostly from renal transplant recipients (n = 11).
Morphology of biofilms was found to be variable, even for biofilms formed by the same species. Six rep-
resentative infection-related isolates of the three species were selected for confocal microscopy analysis. These 
strains showed poor, weak, moderate/strong biofilm formation. All strains formed similar biofilms before and 
after re-emergence as infection related strains in transplant patients (Fig. 2). K. pneumoniae strains 25/27 and 
158/163 formed biofilms with firmly packed, mushroom-shaped microcolony structures. Large red masses can 
be seen inside these structures, possibly due to the early formation of these microcolonies. These structures did 
Mechanisms of resistance to extended-spectrum β-lactams and carbapenems
Species (n° 
strains)
blaCTX-M G1 
(90)
blaCTX-M 
G8 (1)
blaCTX-M G9 
(43)
blaTEM 
(3)
blaSHV 
(18)
AmpC-
hyperproducing (16)
blaOXA-48 
(3) blaVIM (5) blaKPC (2)
blaCTX-M 
G1 + blaOXA-48 (27)
blaCTX-M 
G9 + blaVIM (1)
E. coli (106) 50 (47.2%) 1 (0.9%) 33 (31.1%) 2 (1.9%) 15 (14.1%) 2 (1.9%) — — — 2 (1.9%) 1 (0.9%)
K. pneumoniae 
(78) 39 (50.0%) — 3 (3.8%) 1 (1.3%) 3 (3.8%) — 2 (2.6%) 3 (3.8%) 2 (2.6%) 25 (32.0%) —
Enterobacter 
spp. (25) 1 (4.0%) — 7 (28.0%) — — 14 (56.0%) 1 (4.0%) 2 (8.0%) — — —
Table 1. Distribution of antibiotic resistance genes in Enterobacteriaceae strains. Isolated from transplant 
patients.
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not appear in the biofilms formed by E. coli (weak biofilm formation) which showed a thinner and less compact 
structure. The moderate biofilm producer K. pneumoniae 168/169 formed flat biofilms with loosely packed irreg-
ular microcolony structures and composed mainly by dead cells, as clearly showed by measurements of red/green 
pixel intensities inside biofilms (Supplementary Fig. 1). Moderate or poor biofilm producer strains (according to 
CV data) K. pneumoniae 171/172 and Enterobacter 120/121 respectively, showed few attached cells with loosely 
packed irregular microcolony structures with little heterogeneity.
Infections by MDR in SOT recipients. Transplant recipients were colonized with MDR Enterobacteriaceae 
because the number of MDRE isolates post-transplant was 4.3 times the number of MDRE isolates pre-transplant 
(E. coli 81 vs. 25, K. pneumoniae 67 vs. 11, and Enterobacter 22 vs. 3).
Eight out of 158 (5.1%) patients enrolled in the project developed infection and six of the strains isolated from 
these patients (4%) were re-emergent strains detected in pre-transplant rectal swab samples or colonizers strains 
post-transplant (Fig. 3). All infection related strains were isolated during the first month post-transplant. These 
strains caused urinary infections (K. pneumoniae strain 172 and E. coli strain 199), bacteraemia (Enterobacter 
cloacae strain 121) and abdominal abscesses (K. pneumoniae strain 163) in renal transplant receptors, and skin 
abscess (K. pneumoniae strain 27) and cholecystitis (K. pneumoniae strain 169) in hepatic transplant receptors 
(Supplementary Table 1). Two other strains showing distinct pulsed-field gel electrophoresis (PFGE) patterns 
were not genetically related (not shown) and caused urinary tract infections (E. coli strain 228 and K. pneumoniae 
strain 239) in renal and hepatic transplant recipients, respectively. Patients infected with K. pneumoniae strains 
27, 169 and 172 or E. coli strains 199 and 228 required additional antimicrobial treatment whereas transplant 
Figure 1. Quantification of biofilm formation was performed after Crystal Violet extraction and measurement 
(OD620). Values are presented as mean ± standard deviation of four independent experiments.
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recipients infected with E. cloacae 121, and K. pneumoniae 163 and 239 did not. These infection related strains 
from hepatic transplant recipients formed moderate or strong biofilms, whereas strains from renal transplant 
recipients produced the full range of biofilms (from weak to strong biofilm production). Data on antibiotic resist-
ance, biofilm formation and HA for the eight strains responsible for infection of transplant recipients are sum-
marized in Table 2.
Discussion
Postoperative care of transplant recipients implies frequent manipulations, the use of invasive medical devices, and 
the frequent use of extensive antibiotic therapy, which further contributes to the selection of multidrug-resistant 
bacteria. This cycle is difficult to avoid and leads to a scenario with narrowed therapeutic options. Moreover, 
patients awaiting transplantation could also become colonized with these bacteria.
Biofilm formation is one important characteristic of E. coli and other Enterobacteriaceae27. Biofilm producing 
bacteria may be responsible for many nosocomial infections. Biofilm characteristics protect bacteria from the 
host immune system along with the antibiotics, therefore, the role of biofilms during bacterial infections now 
constitutes an active field of research.
In this study, the ability of biofilm formation in vitro varied extensively among the E. coli isolates, and was 
independent of the type of transplant. The percentage of strains of K. pneumoniae producing biofilm was much 
higher than in E. coli or Enterobacter strains and was similar in kidney and liver transplants. In fact, the rate of 
biofilm formation by Enterobacter strains was very low (4%). Other studies showed similar or slightly higher pro-
portion of Enterobacter strains that can form biofilms28,29. The high rate of biofilm-producing K. pneumoniae and 
the variability among E. coli isolates found in this study are in concordance with other studies evaluating MDR 
strains14,30,31.
We evaluated the possible relationship between biofilm formation and the presence of antimicrobial resistance 
genes. No relationship was found between strong biofilm formation and the presence of resistance genes in the 
three bacterial groups; but among the non-biofilm producers of K. pneumoniae (OD620 ≤ 0.05, n = 16) 11 strains 
were positive for the combination of CTXM-G1 + OXA-48 and other 3 carried the Verona integrin-encoded 
metallo-β-lactamase (VIM). Only 3 K. pneumoniae strains which were unable to form biofilms carried out other 
different resistant genes (strains 80, 83, and 102).
Looking at the type of transplant, there is no significant difference between strains isolated in liver transplan-
tation with respect to kidney transplantation (unpaired t-test, p > 0.05).
K. pneumoniae, E. coli and Enterobacter strains isolated from rectal swabs prior to transplant or isolated 
from rectal swabs during the first weeks after transplantation were found to cause infections in 6 patients. These 
infection-related strains showed the same PFGE pattern and formed similar biofilms that their homologous col-
onizing strains. However, two K. pneumoniae strains (27 and 163) formed more biofilm that their corresponding 
Figure 2. Biofilm formation by the six Enterobacteriaceae strains responsible of infections. These strains were 
compared with their respective isolates pre-transplant (Pre-T) or isolates from rectal swabs post-transplant 
(colonizing strains, C-S). Up: wells were stained with Crystal Violet inside 24-well plates. Source of isolation 
during infections is indicated. Down: representative examples of CLSM images of selected strains after biofilm 
formation. Bacteria were stained with the BacLight LIVE/DEAD viability kit. Live cells fluoresce in green with 
Syto 9 dye and dead cells are stained red with propidium iodide. Original magnification: ×200.
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pre-transplant isolates (25 and 158, paired t-test: p = 0.008 and p = 0.014 respectively). Although infections can 
occur at any time after transplantation, their incidence is highest in the first post-operative month32–34. In our 
study, these reemergent strains cause infections during the first month post-transplant, indicating that early detec-
tion and decolonization of these MDR on time is of critical importance to avoid further complications. However, 
enhanced surveillance monitoring for longer periods regarding opportunistic infections must also be addressed.
HA in E. coli and other Enterobacteriaceae species is mediated by fimbriae. Whereas in chronic conditions 
like urolithiasis biofilm plays an important role in persistence of infection, hemagglutination mediated by type 
I fimbriae, which bind to a mannose-containing receptor, are found in most urinary isolates where plays an 
important role in acute urinary tract infections31,35. The expression of type I fimbriae is indicated by MS hemag-
glutination while MR hemagglutination can be mediated by several types, such as P-fimbriae and DR fimbriae. 
Thus, MRHA-positive isolates can be considered most likely having P or DR fimbriae instead of type I fimbriae. 
Several authors have found a positive correlation between biofilm formation and the presence of type I pili in 
Enterobacteriaceae strains, including E. coli36,37. In this study, the number of E. coli strains that showed MRHA 
(n = 14) was higher than those that showed MSHA (n = 9). Interestingly, the 2 E. coli strains (199 and 228) recov-
ered from infections were both MRHA and produced a very fast hemagglutination of human red blood cells. 
Of note, E. coli hemagglutinating strains but these two, were all poor biofilm producers; therefore, there was no 
correlation between MR or MS hemagglutination of human erythrocytes and biofilm formation.
In this report, we have demonstrated that E. coli and K. pneumoniae isolates display a high degree of pheno-
typic variability, being K. pneumoniae strains the greatest biofilm producers, and that Enterobacter isolates not 
form even moderate biofilms in vitro. Investigation of the mechanisms responsible for strong biofilm formation 
in K. pneumoniae is needed and would clarify some pathogenicity attributes of these bacteria in transplant recip-
ients. On the other hand, as some isolates of the three genera analysed in this study cause infections but did not 
produce biofilms in vitro, it would be worthwhile to identify the presence and significance of other virulence 
factors responsible for the development of recurrent infections after SOT.
Methods
Study population and setting. The present prospective cohort study was conducted between August 
2014 and April 2018 in seven University Hospitals from five Spanish regions. This national project (ENTHERE 
study) focused on the study of intestinal colonization and infections with MDRE in patients with kidney, liver, 
and kidney/pancreas transplants. Transplant patients who have been treated with antibiotics active against MDR 
Figure 3. PFGE profiles of isolates from rectal swabs obtained pre-transplant or isolates from rectal swabs post-
transplant (colonizing strains, C-S) and from infection-related strains (I).
6Scientific RepoRts | (2019) 9:8928 | https://doi.org/10.1038/s41598-019-45060-y
www.nature.com/scientificreportswww.nature.com/scientificreports/
Enterobacteriaceae (in the 30 days prior to inclusion in the study) such us colistin, carbapenems, amikacin or tige-
cycline, or patients who are participating in another study or clinical trial that includes active antibiotic treatment 
were not included in this study.
Bacterial strains. Over a period of 33 months, from October 2014 to June 2017, a total of 209 MDRE iso-
lates defined as AmpC-hyperproducing and/or extended-spectrum β-lactamases (ESBLs) or carbapenemases 
producers, were included in this study. MDRE were obtained from 158 patients with kidney (n = 93) or liver 
transplant (n = 60) or both kidney and pancreatic transplant (n = 5) from the ENTHERE study. Among these, 
106 were Escherichia coli, 78 were Klebsiella pneumoniae, and 25 were Enterobacter spp. (Supplementary Table 1). 
Bacteria were isolated from rectal swabs (in the 48 h previous to transplant and weekly samples till 4–6 weeks after 
transplantation) and directly inoculated onto chromID® ESBL and chromID® CARBA chromogenic agar plates 
(bioMérieux, Marcy L’Etoile, France). Colonies were subcultured on blood agar and MacConkey agar and prelim-
inary identification and antimicrobial susceptibility testing the Vitek 2 compact system (bioMérieux, France) was 
used. Identification was confirmed by MALDI-TOF using the Vitek MS (bioMérieux) system, in accordance with 
manufacturer’s instructions. Stock cultures were frozen at −80 °C with 20% (vol/vol) glycerol.
Molecular characterization of resistance genes. Standard PCR were used to amplify several genes 
encoding extended-spectrum β-lactamases (blaTEM, blaSHV and blaCTXM) and carbapenemases (blaKPC, blaVIM, 
blaIMP, blaNDM and blaOXA-48). PCR multiplex plasmid-mediated AmpC (blaCIT, blaFOX, blaMOX, blaDHA, blaACC and 
blaEBC) was performed as described elsewhere38.
Genomic DNA was extracted using an InstaGeneTM Matrix Kit (Bio-Rad, Madrid, Spain) according to the 
manufacturer’s instructions. Then, 1 µL was added to a reaction mixture containing 1× KAPA Taq ReadyMix 
(KapaBiosystems, Wilmington, USA) and 0.5 µM of each primer. Amplification conditions were 94 °C for 5 min, 
followed by 30 cycles of 94 °C for 30 s, primer annealing at 55, 60 or 64 °C for 30 s and 72 °C for 1 min, and a final 
elongation at 72 °C for 7 min. PCR products were analysed on 2% (wt/vol) agarose gels stained with ethidium 
bromide 10 µg/mL and visualized by UV transillumination.
The amplified products were purified with a QIAquick PCR Purification Kit (QIAGEN Inc., Barcelona, Spain). 
DNA sequences on both strands were determined using an external resource (Macrogen Inc., Amsterdam, The 
Netherlands). Primers used in the detection of antimicrobial resistance genes, expected amplicon sizes, annealing 
temperatures, and references are shown in Supplementary Table 2.
Molecular fingerprinting. Repetitive extragenic palindromic PCR (REP-PCR) typing was performed on all 
isolates as described elsewhere39. Amplicons were run in a 1.5% agarose gel for 100 min, stained with ethidium 
bromide, and photographed. When at least two different bands were observed among isolates clonal relation-
ship was also determined by PFGE. For this purpose, bacterial DNA embedded in agarose plugs was digested 
with the restriction enzyme XbaI and DNA separation was then performed in a CHEF-DRIII variable angle 
system (Bio-Rad, California, USA). Finally, the PFGE patterns were analysed with Fingerprinting II v4.5 software 
(Bio-Rad) and interpreted according to the criteria established by Tenover et al.40.
Strain post-transplant infection Transplant Species aAntibiotic resistance Resistance genes bHA cBiofilm
25 — Renal K. pneumoniae AMX, AMC, AZT, CAZ, CIP, CTX, FEP, FOS, GN, NET, PIP, SXT, TO, TZP blaCTXM-group1 — SB
27 Skin abscess Renal K. pneumoniae AMX, AMC, AZT, CAZ, CTX, FEP, GN, NET, PIP, SXT, TGC, TO, TZP blaCTXM-group1 — SB
120 — Renal E. cloacae AMX, AMC, CTX, FOS, FOX, NAL, PIP, TGC, TZP blaCTXM-group9 — NB
121 Blood Renal E. cloacae AMX, AMC, CTX, FOS, FOX, NAL, PIP, TGC, TZP blaCTXM-group9 — NB
158 — Hepatic K. pneumoniae AMX, AMC, AZT, CAZ, CIP CTX, LEV, NAL, PIP, SXT blaCTXM-group1 — MB
163 Abdominal drainage Hepatic K. pneumoniae AMX, AMC, AZT, CAZ, CIP CTX, FEP, FOX, LEV, NAL, PIP, SXT, TGC blaCTXM-group1 — SB
168 — Hepatic K. pneumoniae AMX, AMC, AZT, CAZ, CIP, COL, CTX, ETP, FEP, FOS, FOX, IMP, LEV, MRP, NAL, NET, PIP, TO, TZP blaCTXM-group1 + blaOXA-48 — MB
169 Bile Hepatic K. pneumoniae AMX, AMC, AZT, CAZ, CIP, CTX, ETP, FEP, FOS, FOX, IMP, LEV, MRP, NAL, PIP, TGC, TO, TZP blaCTXM-group1 + blaOXA-48 — MB
171 — Renal K. pneumoniae AMX, AMC, AZT, CTX, CAZ, CIP, ETP, FEP, FOS, FOX, GN, LEV, NAL, NET, PIP, TO, TGC, TZP blaCTXM-group1 + blaOXA-48 — NB
172 Urine Renal K. psneumoniae AMX, AMC, AZT, CTX, CAZ, CIP, ETP, FEP, FOS, FOX, LEV, NAL, PIP, SXT, TGC, TZP blaCTXM-group1 + blaOXA-48 — NB
198 — Renal E. coli AMX, AMC, AZT, CTX, CIP, LEV, NAL, NET, PIP, SXT, TO blaCTXM-group1 MRHA WB
199 Urine Renal E. coli AMX, AMC, AZT, CTX, CIP, LEV, NAL, NET, PIP, SXT, TO blaCTXM-group1 MRHA WB
Table 2. Characteristics of the eight strains responsible for infection of transplant recipients. aAMX, 
amoxicillin; AMC, amoxicillin-clavulanic acid; AMK; amikacin; AZT, aztreonam; CAZ, ceftazidime; CIP, 
ciprofloxacin; COL, colistin; CTX, cefotaxime; ERT, ertapenem; FEP, cefepime; FOS, fosfomycin; FOX, 
cefoxitin; GN, gentamicin; IMP, imipenem; LEV, levofloxacin; MRP, meropenem; NAL, nalidixic acid; NET, 
netilmicin; PIP, piperacillin; SXT, trimethoprim–sulfamethoxazole;TIG, tigecycline TO, tobramycin; TZP, 
piperacillin-tazobactam. bMRHA, mannose-resistant hemagglutination. cBiofilm formation: NB, non-biofilm; 
WB, weak; MB, moderate; SB, strong.
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Biofilm formation. Biofilm formation was estimated in 24-well polystyrene plates (Corning, Costar) as pre-
viously described41. Briefly, Enterobacteriaceae strains were grown in Luria broth medium for 24 h at 37 °C with 
shaking, and a 1:1,000 dilution was prepared in Luria broth. Twenty-five microliters were placed in each well 
containing 1.5 ml of culture medium. The plates were incubated for 48 h at 37 °C in static. Planktonic cells were 
removed and wells containing biofilms were rinsed three times with distilled water and the remaining adherent 
bacteria were stained with 2 ml/well of crystal violet (0.7% [wt/vol] solution; Sigma-Aldrich) for 12 min. Excess 
stain was removed by washes with distilled water. CV was extracted by acetic acid (33% [vol/vol]), and the plates 
were incubated at room temperature in a bench orbital shaker for 1 min at 400 rpm to release the dye into the 
solution. Then, two samples of 100 µl from each well were transferred to a 96-well flat-bottom plate, and the 
amount of dye was determined at 620 nm using a microplate reader (Multiskan FC; Thermo Fisher). In each 
experiment, results were corrected for background staining by subtracting the value for crystal violet bound 
to uninoculated controls. The assays were performed 4 times for each isolate and the mean ± SD was reported. 
Strains were classified as non-adherent, weak, moderate or strong biofilm producers using the following criteria: 
OD ≤ 0.05, non-biofilm producer; OD > 0.05–0.1 weak biofilm producer; OD > 0.1–0.3 moderate biofilm pro-
ducer; and OD > 0.3 strong biofilm producer.
Confocal laser scanning microscopy (CLSM). Biofilm architecture of selected strains was studied in 
4-well µ-slides (Ibidi, Martinsried, Germany) as previously described41. Briefly, the slides were placed inclined 
(~45°) into an incubator to form a liquid-air interface and after 48 h at 37 °C, unfixed planktonic cells were 
removed by rinsing with saline (0.85% NaCl), and bacterial viability within biofilms was determined by using 
the BacLight LIVE/DEAD bacterial viability kit (Molecular Probes Inc.). A series of optical sections was obtained 
with a Nikon A1R confocal microscope; the excitation wavelengths were 488 nm (green) and 561 nm (red), and 
500 to 550 nm and 570 to 620 nm emission filters were used, respectively. Images at the liquid-air interface were 
captured at random with a 20× Plan Apo (numerical aperture [NA], 0.75) objective. Reconstructions of confocal 
sections and quantitative measurements were performed using NIS-Elements software, version 3.2.
Hemagglutination and HA inhibition tests. To identify other factors associated with biofilm formation 
in E. coli strains, we studied their hemagglutinating activities with human group A erythrocytes and the mannose 
sensitivities of these agglutinations as previously described41. Human erythrocytes were obtained from healthy 
volunteers after informed consent. Hemagglutination tests were performed on microscope slides using 10% sus-
pensions of human group A erythrocytes. E. coli were cultured at 37 °C for 24 h in Luria medium, washed, and 
suspended in PBS to a concentration of ~5 × 109 CFUs per ml. Twenty-five microliters of cultures were mixed 
with 50 µl of erythrocytes with or without 1% D-mannose (Sigma). Agglutination of erythrocytes was examined 
visually after a short period (up to 1 min) of rocking at RT. Hemagglutination was considered resistant to man-
nose when it occurred despite the presence of mannose and sensitive to mannose when it was inhibited by the 
presence of this carbohydrate.
Statistical analysis. Data were described with means and standard deviation. Comparisons of the quantita-
tive data was carried out by comparing means with the paired or unpaired t-test as corresponding. The alpha error 
was set at 0.05, and all p values were bilateral.
Ethical approval and informed consent. The study was performed in accordance with the Declaration of 
Helsinki. The protocol was reviewed and approved by the Institutional Ethics Committee at all seven participat-
ing hospitals according to local standards (EUDRAT-). The participating hospitals were: Hospital Universitario 
Marqués de Valdecilla (Santander), Coordinating Center; Hospital Universitario Cruces (Baracaldo); Hospital 
Clínic Universitari (Barcelona); Hospital General Universitario Gregorio Marañón (Madrid); Hospital 
Universitario 12 de Octubre (Madrid); Hospital Universitario Reina Sofía (Córdoba) and Hospital Universitario 
Ramón y Cajal (Madrid). Informed consent was obtained from each patient.
Data Availability
All data generated or analysed during this study are included in this published article (and its Supplementary 
Information files).
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